Humanigen, Inc
HGENDelisted Oct 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001293310
Humanigen, Inc was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Oct 20, 2023; 38 institutions reported holding it in 13F filings for Q2 2023, worth $839.7K in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Humanigen, Inc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 53 | 1 | 48 | −4 |
| Shares | 7.28M | 10.5K | 7.12M | −147.5K (−2.0%) |
| Value | $1.32M | $19.0K | $851.4K | −$453.9K (−34.8%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Humanigen, Inc at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acadian Asset Management LLC | 191,726 | $23.0K | 0.00% |
| Valeo Financial Advisors, LLC | 30,000 | $3.60K | 0.00% |
| JustInvest LLC | 17,703 | $2.12K | 0.00% |
| LPL Financial LLC | 15,740 | $1.89K | 0.00% |
| StoneX Group Inc. | 14,134 | $1.70K | 0.00% |
| FMR LLC | 1 | $0 | 0.00% |
Sold out (10)
Institutions that held Humanigen, Inc at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Gsa Capital Partners LLP | 1,026,643 | $185.0K |
| Man Group plc | 87,586 | $16.0K |
| Captrust Financial Advisors | 61,000 | $11.0K |
| Susquehanna Fundamental Investments, LLC | 43,575 | $8.00K |
| Qube Research & Technologies Ltd | 38,691 | $7.00K |
| LMR Partners LLP | 17,406 | $3.00K |
| Bayesian Capital Management, LP | 18,400 | $3.00K |
| Pinnacle Associates Ltd | 12,500 | $2.00K |
| Commonwealth Equity Services, LLC | 10,690 | $1.00K |
| TCI Wealth Advisors, Inc. | 500 | $0 |
Not filed for Q4 2022 yet (1)
Institutions that held Humanigen, Inc at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Corient Capital Partners, LLC | 10,461 | $19.0K |